0001127602-23-009138.txt : 20230306
0001127602-23-009138.hdr.sgml : 20230306
20230306174734
ACCESSION NUMBER: 0001127602-23-009138
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230306
FILED AS OF DATE: 20230306
DATE AS OF CHANGE: 20230306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SAUNDERS BRENT L
CENTRAL INDEX KEY: 0001268854
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41380
FILM NUMBER: 23710203
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
STREET 2: C/O SCHERING PLOUGH CORP
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bausch & Lomb Corp
CENTRAL INDEX KEY: 0001860742
STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 520 APPLEWOOD CRESCENT
CITY: VAUGHAN
STATE: A6
ZIP: L4K 4B4
BUSINESS PHONE: 908-541-5456
MAIL ADDRESS:
STREET 1: 520 APPLEWOOD CRESCENT
CITY: VAUGHAN
STATE: A6
ZIP: L4K 4B4
3/A
1
form3a.xml
PRIMARY DOCUMENT
X0206
3/A
2023-03-06
2023-03-06
0
0001860742
Bausch & Lomb Corp
BLCO
0001268854
SAUNDERS BRENT L
C/O BAUSCH + LOMB CORPORATION
520 APPLEWOOD CRESCENT
VAUGHAN
A6
L4K 4B4
ONTARIO, CANADA
1
1
CEO and Chair
Common Shares, No Par Value
375000
D
Non-Qualified Stock Options (right to purchase)
18.60
Common Shares, No Par Value
1318681
D
Performance Stock Units
0
Common Shares, No Par Value
750000
D
Reflects an award of restricted stock units ("RSUs") granted to the reporting person under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") on February 23, 2023. Each RSU reflects the right to receive one common share, no par value ("Common Share"), of Bausch + Lomb Corporation (the "Company"), subject to the terms of the Plan and the applicable award agreement. The RSUs are scheduled to vest 50% on the second anniversary of the grant date and the remaining 50% on the third anniversary of the grant date, subject generally to the reporting person's continued employment through the applicable vesting date.
Reflects an award of stock options to purchase Common Shares granted to the reporting person under the Plan on February 23, 2023. Each stock option reflects the right to purchase one Common Share, subject to the terms of the Plan and the applicable award agreement. The stock options are scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject generally to the reporting person's continued employment through the applicable vesting date.
The stock options will expire on the tenth anniversary of the grant date.
Represents an award of performance stock units ("PSUs") granted to the reporting person under the Plan on February 23, 2023. Each PSU reflects the right to receive one Common Share, subject to the terms of the Plan and the applicable award agreement. The target number of shares underlying the PSUs is 750,000 Common Shares, and the maximum number of shares underlying the PSUs is 2,250,000 Common Shares.
The PSUs may be earned and vest between 0% and 300% based on achievement of specified share price performance goals (and, if applicable, a relative total shareholder return performance goal), calculated as of the fourth anniversary of the grant date (the "Measurement Date"), subject generally to the reporting person's continued employment through the Measurement Date.
No equity changes to originally filed Form 3; submitting Form 3/A to include Limited Power of Attorney.
/s/ Debra E. Levin, attorney-in-fact
2023-03-06
EX-24
2
doc1.txt
POWER OF ATTORNEY (PUBLIC): LIMITEDPOA
POWER OF ATTORNEY
Know all by these presents that the undersigned hereby constitutes
and appoints each of Christina M. Ackermann, Alex Matheson and Debra E.
Levin, or any of them signing singly, and with full power of substitution,
the undersigned's true and lawful attorney-in-fact to:
(1) prepare, execute in the undersigned's name and on the
undersigned's behalf, and submit to the U.S. Securities and Exchange
Commission (the "SEC") a Form ID, including amendments thereto, and
any other documents necessary or appropriate to obtain codes and passwords
enabling the undersigned to make electronic filings with the SEC of reports
required by Section 16(a) of the Securities Exchange Act of 1934 (the
"Exchange Act") or any rule or regulation of the SEC;
(2) execute for and on behalf of the undersigned, in the
undersigned's capacity as a director and/or officer of Bausch +
Lomb Corporation (the "Company"), Forms 3, 4 and 5 in accordance with
Section?16(a) of the Exchange Act and the rules thereunder;
(3) do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and
execute any such Form 3, 4 and 5 complete and execute any amendment
or amendments thereto, and timely file such form with the SEC and any
stock exchange or similar authority; and
(4) take any other action of any type whatsoever in connection
with the foregoing which, in the opinion of such attorney-in-fact, may
be of benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this Power
of Attorney shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in such attorney in
fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of
the rights and powers herein granted, as fully to all intents and purposes
as the undersigned might or could do if personally present, with full
power of substitution or revocation, hereby ratifying and confirming
all that such attorney-in-fact, or such attorney-in-fact's substitute
or substitutes, shall lawfully do or cause to be done by virtue of this
power of attorney and the rights and powers herein granted. The undersigned
acknowledges that the foregoing attorneys in fact, in serving in such
capacity at the request of the undersigned, are not assuming, nor is the
Company assuming, any of the undersigned's responsibilities to comply with
Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect
to the undersigned's holdings of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.
[REMAINDER OF PAGE INTENTIONALY LEFT BLANK]
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed on the date set forth below.
By: /s/ Brent L. Saunders
Name: Brent L. Saunders
Date: March 6, 2023